Results 131 to 140 of about 25,017 (220)

Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill. [PDF]

Viruses
Wu G, Sardo L, Li Y, Heron SD, Shyong B, Mazur M, Gorman DM, Balibar CJ, Magliaro BC, Leach C, Rush T, Howell BJ.   +11 more
europepmc   +1 more source

Glycoform-Dependent Antigenicity in gp120 of HIV-1 Envelope Protein

Trends in Glycoscience and Glycotechnology, 2014
openaire   +2 more sources

Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer. [PDF]

J Biol Chem
Nawaz FZ, Adams TM, Demirturk ME, Avci FY.   +3 more
europepmc   +1 more source

Molecular factors associated with lung cancer in people living with HIV. [PDF]

Braz J Infect Dis
Bautista-Rojas ID, Figueroa-Navarrete J, Reyes-Hernandez DL, Rivera-Toledo E.   +3 more
europepmc   +1 more source

AS01_B-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702. [PDF]

Front Immunol
Menezes F, Chen S, Grunenberg N, Malahleha M, Mngadi K, Muyoyeta M, Laher F, Chirenje ZM, Bekker LG, Goepfert P, Gray GE, Tomaras G, McElrath MJ, Kallas E, Roxby AC, Moodie Z.   +15 more
europepmc   +1 more source

Comprehensive analysis of gp120 glycosylation to explore differences between transmitter/founder and chronic HIV-1 isolates. [PDF]

Glycobiology
Temesy S, Haly J, Sun Y, Patel M, Zebian N, Saha R, Galappaththi SL, Zhang Y, Twells N, Mahal LK, Arts EJ, Creuzenet C.   +11 more
europepmc   +1 more source

Framework-mediated binding of foreign and self-glycans by IGHV4-34 antibodies. [PDF]

Front Immunol
Langley DB, Jara CJ, Henry JY, Reed JH, Goodnow CC, Christ D.   +5 more
europepmc   +1 more source

Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV. [PDF]

J Infect Dis
Benlarbi M, Richard J, Clemente T, Bourassa C, Tolbert WD, Prakash M, Chandravanshi M, Clark A, Pazgier M, Durand M, Castagna A, Finzi A.   +11 more
europepmc   +1 more source

Human immunodeficiency virus vaccines: Advances, challenges and future perspectives. [PDF]

World J Virol
Varatharajan S, Krishnasai S, Girish C.
europepmc   +1 more source

Impact of cellular proteases on the function of antiviral antibodies. [PDF]

J Virol
Krzypow M, Schwartz O, Bruel T, Cottignies-Calamarte A.   +3 more
europepmc   +1 more source